Cargando…
MiR-141-3p overexpression suppresses the malignancy of osteosarcoma by targeting FUS to degrade LDHB
Osteosarcoma (OS) is a common malignant bone cancer. Lactate dehydrogenase B (LDHB) has been revealed to act as a tumor promoter in several cancers. It is also revealed to be correlated with poor prognosis in OS, but its molecular mechanism in OS remains veiled. Our work illustrated that LDHB was ov...
Autor principal: | Wang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286874/ https://www.ncbi.nlm.nih.gov/pubmed/32484203 http://dx.doi.org/10.1042/BSR20193404 |
Ejemplares similares
-
[Retracted] miR‑141‑3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells
por: Wang, Nan, et al.
Publicado: (2023) -
miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma
por: Wang, Jiashi, et al.
Publicado: (2018) -
miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction]
Publicado: (2023) -
MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma
por: Kumar, Satendra, et al.
Publicado: (2018) -
LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid
por: Decking, Sonja-Maria, et al.
Publicado: (2022)